Detalhe da pesquisa
1.
Restoring the association of the T cell receptor with CD8 reverses anergy in human tumor-infiltrating lymphocytes.
Immunity
; 28(3): 414-24, 2008 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-18342010
2.
Loss of effector function of human cytolytic T lymphocytes is accompanied by major alterations in N- and O-glycosylation.
J Biol Chem
; 287(14): 11240-51, 2012 Mar 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-22334653
3.
Inefficient exogenous loading of a tapasin-dependent peptide onto HLA-B*44:02 can be improved by acid treatment or fixation of target cells.
Eur J Immunol
; 42(6): 1417-28, 2012 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-22678898
4.
A major secretory defect of tumour-infiltrating T lymphocytes due to galectin impairing LFA-1-mediated synapse completion.
Nat Commun
; 7: 12242, 2016 07 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-27447355
5.
Sugars boost exhausted tumor-infiltrating lymphocytes by counteracting immunosuppressive activities of galectins.
Oncoimmunology
; 3: e28783, 2014.
Artigo
em Inglês
| MEDLINE | ID: mdl-25097806
6.
A short treatment with galactomannan GM-CT-01 corrects the functions of freshly isolated human tumor-infiltrating lymphocytes.
Clin Cancer Res
; 20(7): 1823-33, 2014 Apr 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-24526733
7.
Immune suppression in tumors as a surmountable obstacle to clinical efficacy of cancer vaccines.
Cancers (Basel)
; 3(3): 2904-54, 2011 Jul 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-24212939
8.
A galectin-3 ligand corrects the impaired function of human CD4 and CD8 tumor-infiltrating lymphocytes and favors tumor rejection in mice.
Cancer Res
; 70(19): 7476-88, 2010 Oct 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-20719885
9.
Effects of prolactin on cloned human T-lymphocytes.
Endocrine
; 20(1-2): 171-6, 2003.
Artigo
em Inglês
| MEDLINE | ID: mdl-12668883
10.
A reversible functional defect of CD8+ T lymphocytes involving loss of tetramer labeling.
Eur J Immunol
; 32(6): 1688-97, 2002 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-12115652
11.
CD4+ T-cell clones specific for wild-type factor VIII: a molecular mechanism responsible for a higher incidence of inhibitor formation in mild/moderate hemophilia A.
Blood
; 101(4): 1351-8, 2003 Feb 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-12393451